3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Lymphoid
1
Genitourinary
1
Dermatologic
1
Conditions
Melanoma
1
Hodgkin Disease
1
Carcinoma, Transitional Cell
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Peripheral Blood Stem Cell Transplantation
41
fludarabine phosphate
33
Cyclophosphamide
31
Mycophenolic Acid
25
Whole-Body Irradiation
22
Cyclosporine
22
Busulfan
21
Tacrolimus
20
Antilymphocyte Serum
17
Methotrexate
16
Filgrastim
14
Etoposide
12
Radiotherapy
11
Psychiatric Rehabilitation
11
Melphalan
11
Methylprednisolone
10
Flow Cytometry
10
Therapeutics
9
Polymerase Chain Reaction
8
Gemcitabine
8
Rituximab
7
sargramostim
6
Vorinostat
6
Sirolimus
6
Cord Blood Stem Cell Transplantation
6
Transplantation
5
Nivolumab
5
Dexamethasone
5
Calcium Dobesilate
5
Bortezomib
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hodgkin Disease
×
RXDX-106
×
Dermatologic
×
Clear all
NCT03454243
2019-04-25
TITAN
Hoffmann-La Roche
Phase EARLY_PHASE1
Terminated
1 enrolled